FIELD: medicine. SUBSTANCE: this drug capable of selectively stimulating granulo-monocytopoiesis in case of hypoplasia of medullary hemopoiesis caused by cytostatic may find application in medical institutions employing antitumoral drugs for treating cytostatic hemodepressions. Essence of this method resides in using glucuronic acid, substance already known in the art, for new purposes as drug capable of selectively stimulating granulo-monocytopoiesis in case of hypoplasia of medullary hemopoiesis caused by cytostatic with the aim of reducing toxic effect of cytostatics on hemopoiesis due to stimulation of granulo-monocytopoiesis. EFFECT: excellent medicine capable of selectively stimulating granulo-monocytopoiesis. 3 dwg, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL AGENT STIMULATING ERYTHROID AND GRANULOCYTE ERYTHROPOIESIS STEMS AT CYTOSTATIC MYELODEPRESSIONS | 1993 |
|
RU2083201C1 |
MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
METHOD OF GRANULOCYTOPENIA-STIMULATING EFFECT EVALUATION FOR PHARMACOLOGICAL SUBSTANCES | 2006 |
|
RU2332667C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
METHOD OF GRANULOCYTOPOIESIS DEPRESSION CORRECTION IN CYTOSTATIC ACTION | 2008 |
|
RU2366422C1 |
GRANULOMONOCYTOPOIESISSTIMULATING PREPARATION AT HYPOPLASTIC STATES OF BLOOD FORMATION | 2001 |
|
RU2182007C1 |
AGENT STIMULATING ERYTHROIDAL AND GRANULOCYTIC HEMOPOIESIS STEMS IN CYTOSTATIC MYELODEPRESSION | 2003 |
|
RU2243782C1 |
HEMOSTIMULATING AGENT | 1994 |
|
RU2088249C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
Authors
Dates
1994-10-15—Published
1988-02-01—Filed